JULY 2022LIFE SCIENCES REVIEW8CHALLENGES AND OPPORTUNITIES FORBy Robert J. Prill, Artificial Intelligence Director, Data Science, Ferring PharmaceuticalsIN MY OPINIONf conventional drug discovery is akin feeling around in the dark, artificial intelligence (AI) is portrayed as a high-tech flashlight, an essential tool to light the way. Unbridled enthusiasm for AI drug discovery is driving massive investment in AI-drug startups and enticing established pharmaceutical companies to recruit AI talent and seek partnerships with AI-drug outfits. In this moment of rapid technological change, it is a challenge IAI IN DRUG DISCOVERYRobert J. Prill
< Page 7 | Page 9 >